Recommendations for using opioids in chronic non-cancer pain

被引:169
作者
Kalso, E [1 ]
Allan, L
Dellemijn, PLI
Faura, CC
Ilias, WK
Jensen, TS
Perrot, S
Plaghki, LH
Zenz, M
机构
[1] Univ Helsinki, Cent Hosp, Helsinki, Finland
[2] Northwick Pk Hosp & Clin Res Ctr, Harrow HA1 3UJ, Middx, England
[3] St Marks NHS Trust, Harrow, Middx, England
[4] Maxima Med Ctr, Veldhoven, Netherlands
[5] Univ Miguel Hernandez, CSIC, Inst Neurosci, Alicante, Spain
[6] Hosp Hospitaller Order St John God, Vienna, Austria
[7] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark
[8] Hosp Tarnier, Paris, France
[9] Clin Univ St Luc, B-1200 Brussels, Belgium
[10] BG Univ Hosp Bergmannsheil, Bochum, Germany
关键词
opioids; opiates; noncancer pain; guideline;
D O I
10.1016/S1090-3801(02)00143-X
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
1. The management of chronic pain should be directed by the underlying cause of the pain. Whatever the cause, the primary goal of patient care should be symptom control. 2. Opioid treatment should be considered for both continuous neuropathic and nociceptive pain if other reasonable therapies fail to provide adequate analgesia within a reasonable timeframe. 3. The aim of opioid treatment is to relieve pain and improve the patient's quality of life. Both of these should be assessed during a trial period. 4. The prescribing physician should be familiar with the patient's psychosocial status. 5. The use of sustained-release opioids administered at regular intervals is recommended. 6. Treatment should be monitored. 7. A contract setting out the patient's rights and responsibilities may help to emphasize the importance of patient involvement. 8. Opioid treatment should not be considered a lifelong treatment. (C) 2002 European Federation of Chapters of the International Association for the Study of Pain. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:381 / 386
页数:6
相关论文
共 34 条
[1]  
ALLAN L, 2001, BRIT MED J, V322, P1
[2]  
*AM AC PAIN MED, 2001, LONG TERM CONTR SUBS
[3]  
*AM AC PAIN MED, 2002, CONS CHRON OP THER
[4]  
[Anonymous], US OP TREATM CHRON P
[5]   Effects of IV morphine in central pain - A randomized placebo-controlled study [J].
Attal, N ;
Guirimand, F ;
Brasseur, L ;
Gaude, V ;
Chauvin, M ;
Bouhassira, D .
NEUROLOGY, 2002, 58 (04) :554-563
[6]  
Caldwell JR, 1999, J RHEUMATOL, V26, P862
[7]   Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: Results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial [J].
Caldwell, JR ;
Rapoport, RJ ;
Davis, JC ;
Offenberg, HL ;
Marker, HW ;
Roth, SH ;
Yuan, W ;
Eliot, L ;
Babul, N ;
Lynch, PM .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2002, 23 (04) :278-291
[8]   Prolonged treatment with transdermal fentanyl in neuropathic pain [J].
Dellemijn, PLI ;
van Duijn, H ;
Vanneste, JAL .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1998, 16 (04) :220-229
[9]   Randomised double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain [J].
Dellemijn, PLI ;
Vanneste, JAL .
LANCET, 1997, 349 (9054) :753-758
[10]   Opioid substitution to improve the effectiveness of chronic noncancer pain control: A chart review [J].
Do Quang-Cantagrel, N ;
Wallace, MS ;
Magnuson, SK .
ANESTHESIA AND ANALGESIA, 2000, 90 (04) :933-937